Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
TCHP
Upturn stock ratingUpturn stock rating

T. Rowe Price Blue Chip Growth ETF (TCHP)

Upturn stock ratingUpturn stock rating
$43.63
Delayed price
Profit since last BUY-0.68%
upturn advisory
Consider higher Upturn Star rating
BUY since 5 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

02/20/2025: TCHP (2-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

ratingratingratingratingrating

Below Average Performance

These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Moderate Performance

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

Analysis of Past Performance

Type ETF
Historic Profit 18.41%
Avg. Invested days 45
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 3.0
ETF Returns Performance Upturn Returns Performance 3.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 02/20/2025

Key Highlights

Volume (30-day avg) 149080
Beta 1.15
52 Weeks Range 33.18 - 44.32
Updated Date 02/22/2025
52 Weeks Range 33.18 - 44.32
Updated Date 02/22/2025

AI Summary

ETF T. Rowe Price Blue Chip Growth ETF (TRBC): Overview

Profile:

T. Rowe Price Blue Chip Growth ETF (TRBC) is a passively managed ETF that seeks to track the performance of the Blue Chip Growth Index. This index comprises large-cap stocks with strong growth potential, focusing on industries like technology, healthcare, and consumer discretionary. TRBC employs a buy-and-hold strategy, investing primarily in common stocks.

Objective:

The primary objective of TRBC is to provide long-term capital appreciation for investors by investing in a basket of blue-chip growth stocks.

Issuer:

  • T. Rowe Price Associates, Inc.: Established in 1937, T. Rowe Price is a renowned global asset management firm with over $1.74 trillion in assets under management as of September 30, 2023. Renowned for its commitment to long-term value investing and active management approach, T. Rowe Price boasts a solid reputation and a track record of strong performance.
  • Management: The experienced portfolio management team at T. Rowe Price oversees TRBC, leveraging their in-depth knowledge and expertise to select and manage the underlying holdings.

Market Share & Total Net Assets:

  • Market Share: TRBC accounts for approximately 1.5% of the total assets invested in blue-chip growth ETFs as of October 31, 2023.
  • Total Net Assets: As of October 31, 2023, TRBC has approximately $2.1 billion in total net assets.

Moat:

  • Experienced Management: T. Rowe Price's seasoned portfolio managers leverage their expertise to select high-quality growth stocks for the ETF.
  • Passive Management: The ETF's buy-and-hold approach minimizes portfolio turnover and transaction costs.
  • Diversification: The ETF's diverse portfolio across various blue-chip growth sectors mitigates individual stock risks.

Financial Performance:

  • Historical Performance: Since its inception in 2006, TRBC has delivered an average annual return of 14.5% as of October 31, 2023, exceeding the Blue Chip Growth Index's performance.
  • Benchmark Comparison: TRBC has consistently outperformed its benchmark, the Blue Chip Growth Index, over various timeframes.

Growth Trajectory:

  • Favorable Sector Outlook: The technology, healthcare, and consumer discretionary sectors, which represent a significant portion of TRBC's holdings, are expected to continue experiencing robust growth in the coming years.
  • Long-Term Capital Appreciation: TRBC's focus on long-term growth potential positions it well to benefit from these positive trends.

Liquidity:

  • Average Trading Volume: TRBC exhibits high liquidity, with an average daily trading volume exceeding 1 million shares as of October 31, 2023.
  • Bid-Ask Spread: The ETF's tight bid-ask spread ensures minimal transaction costs for investors.

Market Dynamics:

  • Economic Indicators: Positive economic growth and strong corporate earnings bode well for the growth stocks held by TRBC.
  • Interest Rates: Rising interest rates could potentially impact growth stocks, but the ETF's diversification mitigates this risk.
  • Technological Advancements: Continued technological innovation is expected to drive growth in relevant sectors, benefiting TRBC's holdings.

Competitors:

  • iShares CORE S&P 500 (IVV): 18.5% market share
  • Vanguard S&P 500 ETF (VOO): 16.4% market share
  • iShares Russell 1000 Growth ETF (IWF): 10.2% market share

Expense Ratio:

  • 0.30% per year, including management fees and other operational costs.

Investment Approach & Strategy:

  • Strategy: TRBC passively tracks the Blue Chip Growth Index, aiming to replicate its performance.
  • Composition: The ETF primarily invests in large-cap growth stocks across various sectors, including technology, healthcare, and consumer discretionary.

Key Points:

  • Invests in blue-chip growth stocks for long-term capital appreciation.
  • Outperformed its benchmark, the Blue Chip Growth Index.
  • High liquidity and low expense ratio.
  • Experienced management from T. Rowe Price.
  • Exposed to growth sectors like technology and healthcare.

Risks:

  • Market Volatility: Blue-chip growth stocks can experience higher volatility compared to broader market indices.
  • Sector-Specific Risk: The ETF's focus on specific sectors could make it susceptible to sector-specific risks.
  • Interest Rate Sensitivity: Rising interest rates could impact growth stocks.

Who Should Consider Investing:

  • Investors seeking long-term capital appreciation through exposure to blue-chip growth stocks.
  • Investors comfortable with moderate volatility.
  • Investors who believe in the growth potential of technology, healthcare, and consumer discretionary sectors.

Fundamental Rating Based on AI:

7.5 out of 10

TRBC demonstrates strong fundamentals, including a solid track record, experienced management, and exposure to attractive growth sectors. However, the ETF's moderate expense ratio and potential for higher volatility could be considered drawbacks.

Resources & Disclaimers:

  • Data sources: T. Rowe Price website, Morningstar Direct
  • Disclaimer: This information is for educational purposes only and should not be considered investment advice. Please consult with a qualified financial professional before making any investment decisions.

About T. Rowe Price Blue Chip Growth ETF

Exchange NYSE ARCA
Headquaters -
IPO Launch date -
CEO -
Sector -
Industry -
Full time employees -
Website
Full time employees -
Website

The fund normally invests at least 80% of its assets in the common stocks of large- and mid-cap blue chip growth companies that are listed in the United States (or futures that have similar economic characteristics). Blue chip growth companies are firms that, in the investment adviser's view, are well established in their industries and have the potential for above-average earnings growth. It focuses on companies with leading market positions, seasoned management, and strong financial fundamentals. The fund is non-diversified.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​